Hint mode is switched on Switch off

IGM Biosciences, ordinary share
IGMS, US4495851085

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
IGM Biosciences, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
IGM Biosciences, Inc. operates as a biotechnology company. The Company specializes in the research and development for the treatment of cancer. IGM Biosciences serves customers in the United States.
  • Issuer
  • Full borrower / issuer name
    IGM Biosciences, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IGMS
  • Placement
    18.09.2019
  • Lock up period
    180
  • Number of papers
    10,937,500
  • Volume of raised funds
    175 mln USD
  • Placement share
    37.86%
  • Final placement price
    16 USD
  • Price change since placement date
    -100%
  • By capitalization
    462.27 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IGMS
  • Placement
    09.12.2020
  • Lock up period
    180
  • Number of papers
    887,891
  • Volume of raised funds
    79.91 mln USD
  • Placement share
    2.81%
  • Final placement price
    90 USD
  • Price change since placement date
    -100%
  • By capitalization
    2,842.25 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IGMS
  • Placement
    23.06.2023
  • Lock up period
    180
  • Number of papers
    31,097,900
  • Volume of raised funds
    12.78 mln USD
  • Placement share
    5.14%
  • Final placement price
    8 USD
  • Price change since placement date
    -100%
  • By capitalization
    248.78 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
II q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
III q eng
IV q eng
Show more Hide

Indicators

News

14/08/2025 IGM Biosciences: Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departures Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
01/07/2025 IGM Biosciences: Entry Into A Material Definitive Agreement, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensation Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
06/06/2025 IGM Biosciences: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
23/05/2025 IGM Biosciences: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Financial Statements And Exhibits
05/05/2025 IGM Biosciences: Termination Of A Material Definitive Agreement, Regulation Fd Disclosure
All organization news

Holders

Industry Leaders

Registration is required to get access.